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The development of both squamous cell carcinoma (SCC) and
keratoacanthoma (KA) in donor sites following split thickness skin
graft harvest are rare complications reported in the literature.
Management of such cases requires a precise distinction between
keratoacanthoma and SCC and knowledge of the degree of
differentiation.
We describe the case of a 48-year-old male who developed a
squamous cell carcinoma with features of KA within a donor site
on his right thigh. This developed six weeks following split skin
graft harvest to cover a defect on his right anterior chest following
wide local excision of a 2.4 mm Breslow thickness superﬁcial
spreading melanoma.
We review previous cases in the literature along with theories
suggested for their development and conclude the development of
SCC with features of KA in this reported case was likely a de novo
lesion. This case highlights the need for evaluation of the donor
site at all surveillance examinations of the primary tumor site and
urgent diagnostic biopsy of all non-healing and new lesions.
© 2015 The Authors. Published by Elsevier Ltd on behalf of British
Association of Plastic, Reconstructive and Aesthetic Surgeons. This
is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).; fax: þ353 21 221 4020.
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A 48-year-old male was initially referred from dermatology services with a histologically conﬁrmed
superﬁcial spreading melanoma excised from his right anterior chest. This had a reported Breslow
thickness of 2.4 mm with no ulceration, no lymphovascular or perineural invasion, absent regression
and a mitotic count of 2 per mm2. He had no relevant past medical history and reported limited sun
exposure conﬁned to Ireland. On assessment he had Fitzpatrick skin Type 1. There was no history of
previous melanoma or non-melanoma skin cancer and also no relevant family history of note. He
underwent a 2 cmwide local excisionwith split-thickness skin graft (STSG) harvested from right thigh
and sentinel lymph node biopsy excised from right anterior chest wall. The wide local excision was
initially interpreted as showing no microscopic evidence of residual melanoma on hematoxylin and
eosin stain (H&E). However immunohistochemistry showed two separate sub millimeter foci of sub-
capsular tumor cells. One of these deposits was subsequently identiﬁed retrospectively in the H&E
staining. This was discussed at multidisciplinary team (MDT) setting and it was agreed to place him in
surveillance with three monthly axillary ultrasound examinations.
Initial donor site review at two weeks was satisfactory. Six weeks post surgery he developed a
1.5 cm by 0.5 cm nodular lesion at the superolateral aspect of his donor site [Figure 1]. Incisional biopsy
was performed and invasive well-differentiated squamous cell carcinoma (SCC) with cytological fea-
tures of keratoacanthoma (KA) was diagnosed [Figure 2a]. He underwent complete excision in
November 2013. A well-differentiated, invasive squamous cell carcinoma that was fully excised was
diagnosed. The tumor, which was 5.0 mm in diameter, extended into the reticular dermis (Clarke level
IV) [Figure 2b].
Discussion
Keratoacanthoma (KA), an epithelial neoplasm, is considered a well-differentiated form of invasive
SCC. Generally it can be differentiated from SCC on both clinical and histological grounds but despite
novel diagnostic techniques the two pathologies remain closely related.1 Although originally thought
to have a natural tendency towards regression, aggressive and metastatic behavior has been reported
in the context of KA. This has prompted a more cautious approach with most advocating surgical
excision as ﬁrst-line therapy alike the surgical management of SCC.2
The development of SCC in donor sites following split skin graft harvest is rare.3 To date there are
only eleven documented cases (n ¼ 11) in the literature (Table 1). Considering the initial histology in
this case had features of KAwe included four further cases of reported KA in donor sites.4,5 In total oneFigure 1. Photograph of patient's leg with lesion within donor site six weeks post STSG harvest.
Figure 2. a. H&E staining showing keratin pearls typical of squamous cell carcinoma. b. H&E staining showing invasive well-
differentiated squamous cell carcinoma.
Table 1
Comparing characteristics of previously described cases of KA and SCC arising in donor sites.
Year Reference Site of primary
lesion
Nature of primary
lesion
Donor site Time of onset in
donor site (months)
Malignancy
occurring
in donor site
1948 Jeremiah7 N/A For scar contracture Upper arm 6 SCC
1958 Wulsin JH8 Neck BCC Thigh ¾ KA
1987 Hammond et al.9 N/A For acute burn Thigh 3 SCC
1988 Neilson et al.10 Finger SCC Thigh 12 SCC
1989 Soto-de Delas et al.11 a MM Thigh 1 ½ KA
1994 Abadir and Zurowski12 Palm SCC Thigh 8 SCC
1997 Hamilton et al.4 N/A For acute burn Thigh 1 KA
1998 Taylor et al.13 N/A For acute burn Thigh 5 SCC
1999 Tamir et al.5 N/A For acute burn Thigh 4 KA
2008 Haik et al.14 Toe MM Thigh 1 ½ SCC
2010 May and Patil6 Orbit SCC Thigh 6 SCC
2011 Hussain et al.15 Hand SCC Thigh 2 SCC
2011 Ponnuvelu et al.16 Scalp
Leg
BCC
KA
Thigh
Thigh
½
1¼
SCC
SCC
2013 Morritt and Khandwala3 Leg SCC Thigh 27 SCC
2014 Our report Chest MM Thigh 1 ½ SCC
N/A e not applicable.
a Only the abstract was available for review which didn't include site of primary lesion.
L. Kearney et al. / JPRAS Open 3 (2015) 35e38 37case of SCC and one case of KA had developed following split thickness skin graft harvest to cover the
defect following excision of a melanoma. The mean time for development of SCC was 6.6 months
versus 7.3 weeks in reported cases of KA, comparable with our patient's six week interval.
In six of the eleven previously reported SCC cases, no clear causative factor is identiﬁed leading to the
suggestion of a de novo lesion developing.6 Close histological examination of the primary and donor site
lesion in this case showed no similarity between the two and support a de novo lesion developing (Table
1). Risk factors such as Fitzpatrick skin Type I and UV light exposure are common to bothmelanoma and
non-melanoma skin cancers. This further supports the development of a de novo SCC.
The development of SCCs donor sites is rare and several theories have been proposed. This case
serves to highlight another case of de novo SCC development at a distant site. We propose an evalu-
ation of the donor site at all surveillance examinations of the primary tumor site and urgent diagnostic
biopsy of all non-healing and new lesions.Funding
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